Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/20/25 16:36 | 3/18/25 | CADL | Health | BioPrd | Biological Products, (No Diag | Nichols William Garrett | MA | O | Chief Me | 6 | S.d | -753 | 7.45 | 0 | -101 | 125 | D | |||||||||||||||
3/20/25 16:36 | 3/18/25 | CADL | Health | BioPrd | Biological Products, (No Diag | Barone Francesca | MA | O | Chief Sc | 6 | S.d | -759 | 7.02 | 0 | -108 | 174 | D | |||||||||||||||
3/20/25 16:35 | 3/18/25 | CADL | Health | BioPrd | Biological Products, (No Diag | Tak Paul Peter | MA | DO | CEO | 6 | S.m | -1,050 | 6.53 | 0 | -161 | 353 | D | |||||||||||||||
3/20/25 16:35 | 3/17/25 | CADL | Health | BioPrd | Biological Products, (No Diag | Tyagarajan Seshu | MA | O | CTO | 7 | S.d | -1,044 | 7.45 | 0 | -140 | 161 | D | |||||||||||||||
3/19/25 16:06 | 3/17/25 | CADL | Health | BioPrd | Biological Products, (No Diag | Schoch Charles | MA | O | See Rema | 5 | S | -312 | 7.21 | 0 | -43 | 72 | D | |||||||||||||||
10/15/24 17:59 | 10/11/24 | CADL | Health | BioPrd | Biological Products, (No Diag | Aguilar-Cordova Estuardo | MA | T | 2 | S.m | -486 | 6.45 | 0 | -75 | 6,094 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |